A Pair of Tax Loss Rally Candidates to ConsiderBY Helene Meisler Ā· Nov 2, 2026, 6:32 PM ESTGEGSHOODJPMKWEB
This Biotech Got Hit on a Competitorās Good News. Hereās Why Iām AddingBY James "Rev Shark" DePorre Ā· Nov 2, 2026, 12:00 PM ESTAAPLINOMAGS
New CrowdStrike Price Target as AI Update Drive $10 Billion ProjectionBY Stephen Guilfoyle Ā· Nov 2, 2026, 11:30 AM ESTAEXAYBTGOFCRWD
Iām Eying Ocular Therapeutix, Rocket Lab; Also Small Caps SteadyBY Stephen Guilfoyle Ā· Nov 2, 2026, 10:05 AM ESTASPNEVLVOCUL
Going for the āTrifectaā With This Biopharma TradeBY Bret Jensen Ā· Nov 1, 2026, 11:45 AM ESTAMZNANIPGOOG
Investor Sentiment Sends an Overt Warning About the Stock MarketBY Helene Meisler Ā· Nov 1, 2026, 11:42 AM ESTAMZNAPDBYD
Bearish Bets: 3 Stocks Still Trapped in the Bearsā GripBY Bob Lang Ā· Nov 1, 2026, 9:45 AM ESTALNYFTNTSCI
Canāt Stomach Tech Stocks Today? Then Check Out This BiopharmaBY Bret Jensen Ā· Oct 30, 2026, 12:45 PM EDTABBVAMZNGMAB
Intel Downgrade After C-Suiteās Major ErrorBY Stephen Guilfoyle Ā· Oct 30, 2026, 11:35 AM EDTAMDINTCSKHY
Adding to 6 Small-Cap Positions Amid Risk-Off SessionBY Stephen Guilfoyle Ā· Oct 30, 2026, 10:30 AM EDTAMZNASPNEVLV
Will Questionable Tech Earnings Be Enough to Change Sentiment?BY Helene Meisler Ā· Oct 29, 2026, 6:24 PM EDTAAARCSCO
Microsoft Price Target After $25 Billion Bond Sale UpdateBY Stephen Guilfoyle Ā· Oct 29, 2026, 11:15 AM EDTMSFT
Merck Beats Estimates and Appeals as a Long-Term InvestmentBY Ed Ponsi Ā· Oct 29, 2026, 10:35 AM EDTMRK
